Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol NR4A3 contributors: mct - updated : 19-12-2013
HGNC name nuclear receptor subfamily 4, group A, member 3
HGNC id 7982
ASSOCIATED DISORDERS
corresponding disease(s)
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral   translocation    
in extraskeletal and skeletal myxoid chondrosarcoma EMC with t(9;22)(q22;q12) see EWS, EWSR, or t(9;17)(q22;q11),(see TAF2N)
constitutional     --over  
in coronary atherosclerosis, and in atherosclerotic plaques
tumoral fusion      
fused to TFG in myxoid chondrosarcoma
tumoral     --other  
aberrant coexpression with SIX3 is a potential alternative mechanism underlying the development of extraskeletal myxoid chondrosarcomas
constitutional     --over  
in human endothelial cells increased the expression of vascular cell adhesion molecule VCAM1 and intercellular adhesion molecule-1
tumoral     --low  
of NR4A1 and NR4A3 was a common feature in leukemic blasts from human acute myeloid leukemia patients
Susceptibility
Variant & Polymorphism
Candidate gene
Marker
  • pathognomic rearrangement of NR4A3 is a useful diagnostic feature in identifying cellular extraskeletal myxoid chondrosarcoma
  • Therapy target
    SystemTypeDisorderPubmed
    cardiovascular  
    blockage of NR4A3 could be useful to prevent vascular effects triggered by thrombin
    cancer  
    identification of pro-apoptotic agents inducing NR4A expression or acting as agonists suggests that these members could serve as potential targets for cancer therapy
    ANIMAL & CELL MODELS
  • expression increased in diabetic mice that exhibit elevated gluconeogenesis
  • Nor1 deficiency reduces hypercholesterolemia-induced atherosclerosis formation in apoE(-/-) mice by decreasing the macrophage content of the lesion